Joanna Ptolomey Digital industries: a road to nowhere?
Jinfo Blog

Monday, 27th September 2010 Sign in to MyJinfo or create an account be able to star items Printable version Subscribe via RSS to get updates as soon as Blog items are added

By Joanna Ptolomey

Item

From TV to economies – it is all about ‘digital’. Hardly a minute goes by without someone mentioning the ‘digital world’ in which we live, work and play. I picked up the Financial Times today and read an advert from an IBM campaign - ‘smarter planet is a more secure planet’ – where their estimates of information created content will ‘quintuple in the next 2 years to more than 2.5 zettabytes’. In organisations and as individuals we make decisions every day about what to buy and try in this digital world. Are we driven by what we actually need, by what looks shiny or by what others seem to using or talking about? Probably a combination of all. And how much are we bounded by the industry sector in which we work in? This week I will be at DigiPharm (http://digbig.com/5bcmbx) – a meeting of minds for the pharmaceutical sector marketing and communications folks. It will be a showcase of debate about online communication and customer relationship in a heavily regulated industry. Part of me is hoping for a good old fashioned bun fight – you can follow the conversation on twitter at #digipharm. ‘Becoming digital’ is not an overnight decision even if you wholeheartedly want to embrace this model of business. It requires a shift in culture combined with the good sense to know that the offline world is still important. Building two way relationships is also a part of the ‘digital world’ – easy to say, but harder to achieve especially if part of your engagement is with patients suffering from chronic disease or acute medical conditions and their health care providers. So hold on there uneasy partners – does the pharmaceutical industry need a new way to manage this change? How can this ‘community’ work together? What have they already learned, achieved and where will they go now? How do you facilitate the conversation between the patient, the provider and the industry? I have a vested interest in the STM industry sector. The pharmaceutical sector is one part of this industry – but we all need everyone to turn up for the bun fight to make it work. I will be reporting from #digipharm on trends, conversations, transformational changes and the occasional bun fight. I am hoping that lessons can be transferred to other industries too. Watch this space…………

« Blog

What's new at Jinfo?

Focus on Value Chain

Document the value chain, and transform the way you think about, manage and report on your product portfolio and your information service contributions to your organisation goals.

Focus on Value Chain


Focus on Risk Assessment

Risk assessment is a required process for a healthy information department. It gauges the ability of your services, team, portfolio and overall value to withstand stress.

Focus on Risk Assessment

Sorry, there seems to be a problem with Webinar and Community listings. Please let us know, by email to support@jinfo.com. Thank you.

Benefit from our research

Our proven processes, resources and guidance will help your team make the shift from transaction centre to strategic asset.


Workshops

Designed around the most common challenges and pain points for time- and resource-strapped information teams

Supercharge remote productivity and value
Holistic content portfolio management
Future-proof your information service
Executive-ready communications


Briefings

A tailored overview of our research and active discussion with your Jinfo analyst.


Assessments

Measure your starting point to articulate your strengths and set priorities for future improvements. Assessments gauge risk, capacity, value and more.


Read case studies, and start the conversation:

Consulting benefits

Connect your team with the practical tools, original research and expertise to build and support information strategy in your organisation.

A Jinfo Subscription gives access to all Content (articles, reports, webinars) and Community.

Subscription benefits